Your SlideShare is downloading. ×

[Infographic] Lung Cancer

431
views

Published on

Lung Cancer is the leading cause of cancer death. It claims more lives each year than do colon, prostate, ovarian and breast cancers combined. ISR explores risk factors, treatment, and drug …

Lung Cancer is the leading cause of cancer death. It claims more lives each year than do colon, prostate, ovarian and breast cancers combined. ISR explores risk factors, treatment, and drug development in this infographic.
- See more at: http://www.isrreports.com/free-resources/3595/#sthash.f3suitGk.dpuf

Published in: Health & Medicine, Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
431
On Slideshare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
7
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Lung cancer claims more lives each year than do colon, prostate, ovarian and breast cancers combined. 39,620 Breast Cancer 50,310 Colon Cancer 14,270 Ovarian Cancer 159,260Lung Cancer ONE IN 13 MEN WILL DEVELOP LUNG CANCER. ONE IN 16 WOMEN WILL DEVELOP LUNG CANCER. DEATHS PER YEAR TREATMENT 2/3 OF PEOPLE WITH LUNG CANCER ARE DIAGNOSED AT AGE 65 OR OLDER AT LEAST 80% OF LUNG CANCER DEATHS ARE THOUGHT TO RESULT FROM SMOKING. For stage I and II, surgery remains the primary treatment . Patients often undergo either radiation therapy, systemic chemotherapy, molecular-targeted therapy, stage-based management or a combination of these. + + LUNG CANCERIS THE LEADING CAUSE OF CANCER DEATH. RISKFACTORS INFO@ISRREPORTS.COM @ISRREPORTS ISRREPORTS.COM Sources: ISR Reports, cancer.org, cancer.gov, mayoclinic.org, dailyinfographic.org DRUG DEVELOPMENT PATIENTS ON THE RELATIVELY NEW DRUG AFATINIB WILL EXPERIENCE, ON AVERAGE, A FULL YEAR BEFORE THEIR TUMOR CONTINUES GROWING – COMPARED TO PATIENTS ONLY ON CHEMOTHERAPY WHO EXPERIENCE TUMOR GROWTH IN UNDER HALF A YEAR. OVER 50 DRUGS ARE IN THE LATE STAGES OF CLINICAL TRIALS. DOWNLOAD ISR’S “LUNG CANCER: CLINICAL TRIALS” REPORT TO LEARN MORE. SmokingExposure to secondhand smoke radon gas asbestos